Source: MarketScreener

Alfasigma: GlobalData : Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData

(marketscreener.com) 28 Sep, 2023 Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData Share Print page Posted in Pharma The acquisition of Intercept Pharmaceuticals by the Italian pharmaceutical company Alfasigma became...https://www.marketscreener.com/quote/stock/GLOBALDATA-PLC-13101755/news/GlobalData-Intercept-acquisition-by-Alfasigma-reflects-NASH-failure-says-GlobalData-44935647/?utm_medium=RSS&utm_content=20230928

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Francesco Balestrieri's photo - CEO of Alfasigma

CEO

Francesco Balestrieri

CEO Approval Rating

90/100

Read more